- Home
- EFSC vs HRMY Comparison
EFSC vs HRMY Comparison
Compare EFSC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSC
- HRMY
- Stock Information
- Founded
- EFSC 1988
- HRMY 2017
- Country
- EFSC United States
- HRMY United States
- Employees
- EFSC N/A
- HRMY N/A
- Industry
- EFSC Major Banks
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- EFSC Finance
- HRMY Health Care
- Exchange
- EFSC Nasdaq
- HRMY Nasdaq
- Market Cap
- EFSC 2.0B
- HRMY 1.8B
- IPO Year
- EFSC 1999
- HRMY 2020
- Fundamental
- Price
- EFSC $58.07
- HRMY $34.71
- Analyst Decision
- EFSC Strong Buy
- HRMY Strong Buy
- Analyst Count
- EFSC 3
- HRMY 9
- Target Price
- EFSC $64.33
- HRMY $54.44
- AVG Volume (30 Days)
- EFSC 196.4K
- HRMY 604.5K
- Earning Date
- EFSC 07-28-2025
- HRMY 08-05-2025
- Dividend Yield
- EFSC 2.05%
- HRMY N/A
- EPS Growth
- EFSC 9.23
- HRMY 13.13
- EPS
- EFSC 5.09
- HRMY 2.62
- Revenue
- EFSC $619,222,000.00
- HRMY $744,852,000.00
- Revenue This Year
- EFSC $14.06
- HRMY $20.33
- Revenue Next Year
- EFSC $4.85
- HRMY $17.67
- P/E Ratio
- EFSC $11.50
- HRMY $12.97
- Revenue Growth
- EFSC 6.50
- HRMY 20.62
- 52 Week Low
- EFSC $43.33
- HRMY $26.47
- 52 Week High
- EFSC $63.13
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- EFSC 65.09
- HRMY 63.75
- Support Level
- EFSC $56.49
- HRMY $33.76
- Resistance Level
- EFSC $58.17
- HRMY $35.08
- Average True Range (ATR)
- EFSC 1.14
- HRMY 0.91
- MACD
- EFSC 0.23
- HRMY 0.32
- Stochastic Oscillator
- EFSC 85.38
- HRMY 90.34
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.